ESC Premium Access

The importance of type of antithrombotic treatment after aortic valve replacement for the risk of future thromboembolic and bleeding events in aortic stenosis - Comparison of mechanical -, bio prosthetic and trans-catheter (TAVI) aortic valve replacement.

Congress Presentation

About the speaker

Associate Professor Christina Christersson

Uppsala University, Uppsala (Sweden)
5 presentations
1 follower

4 more presentations in this session

Modeling the Individual Risk of Thrombosis in Oncology (MIRTO).

Speaker: Doctor J. Soria Fernandez (Sant Pau, ES)

Thumbnail

Dual approach cardiac MRI for molecular assessment and interventional treatment of vulnerable coronary plaques in a porcine model.

Speaker: Professor T. Heidt (Buhl, DE)

Thumbnail

Systemic versus site targeted treatment of neoatherosclerosis.

Speaker: Doctor M. Joner (Munich, DE)

Thumbnail

Identification of mirRNA profiles associated with venous thromboembolism and recurrent events (IMPROVEMENTS).

Speaker: Doctor D. Tregouet (Paris, FR)

Thumbnail

Access the full session

ESC Grants for Medical Research Innovation

Speakers: Associate Professor C. Christersson, Doctor J. Soria Fernandez, Professor T. Heidt, Doctor M. Joner, Doctor D. Tregouet
Thumbnail

About the event

Image

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations